Furthermore, we aimed to investigate the response of CHP-134 cells in which PHLDA1 was silenced to doxorubicin to examine whether a similar regulatory effect could be observed in yet another neuroblastoma cell line. The gene discussed is PHLDA1; the disease is neuroblastoma.